oxybutynin has been researched along with methylphenidate in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 9 (90.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bell, GH; Griffin, WC; Novak, AJ; Patrick, KS | 1 |
| Buhse, LF; Doub, WH; Machado, SG; Shen, M; Wokovich, AM | 1 |
| Marchant, BK; Olsen, JL; Reimherr, FW; Robison, RJ; Wender, PH | 1 |
| Keating, GM | 1 |
| Dinh, S; Findling, RL | 1 |
| Faraone, SV; Hammerness, PG; Wilens, TE | 1 |
| Brinker, A; Cheng, C; Diak, IL; La Grenade, L; Levin, RL | 1 |
3 review(s) available for oxybutynin and methylphenidate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Transdermal therapy for attention-deficit hyperactivity disorder with the methylphenidate patch (MTS).
Topics: Administration, Cutaneous; Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clinical Trials as Topic; Humans; Methylphenidate; Transdermal Patch | 2014 |
Drugs for ADHD.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Delayed-Action Preparations; Humans; Methylphenidate; Risk Factors; Transdermal Patch | 2015 |
3 trial(s) available for oxybutynin and methylphenidate
| Article | Year |
|---|---|
Oppositional defiant disorder in adults with ADHD.
Topics: Adult; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Comorbidity; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Memory, Episodic; Methylphenidate; Personality Disorders; Psychiatric Status Rating Scales; Substance-Related Disorders; Transdermal Patch | 2013 |
Methylphenidate transdermal system in attention-deficit hyperactivity disorder in adolescents: profile report.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Double-Blind Method; Humans; Methylphenidate; Transdermal Patch | 2012 |
Reliability and Validity of the Before-School Functioning Scale in Children With ADHD.
Topics: Administration, Cutaneous; Attention Deficit Disorder with Hyperactivity; Behavior Rating Scale; Child; Cross-Over Studies; Dopamine Uptake Inhibitors; Executive Function; Female; Humans; Male; Methylphenidate; Reproducibility of Results; School Health Services; Schools; Surveys and Questionnaires; Time Factors; Transdermal Patch; Treatment Outcome | 2018 |
4 other study(ies) available for oxybutynin and methylphenidate
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Transdermal and oral dl-methylphenidate-ethanol interactions in C57BL/6J mice: transesterification to ethylphenidate and elevation of d-methylphenidate concentrations.
Topics: Administration, Cutaneous; Administration, Oral; Animals; Biological Availability; Biotransformation; Brain; Central Nervous System Stimulants; Drug Interactions; Esterification; Ethanol; Gas Chromatography-Mass Spectrometry; Intestinal Absorption; Isomerism; Male; Methylphenidate; Mice; Mice, Inbred C57BL; Skin Absorption; Transdermal Patch | 2011 |
Evaluating elevated release liner adhesion of a transdermal drug delivery system (TDDS): a study of Daytrana™ methylphenidate transdermal system.
Topics: Adhesiveness; Administration, Cutaneous; Central Nervous System Stimulants; Drug Delivery Systems; Drug Packaging; Drug Stability; Humans; Linear Models; Methylphenidate; Transdermal Patch | 2011 |
Chemical Leukoderma Associated with Methylphenidate Transdermal System: Data From the US Food and Drug Administration Adverse Event Reporting System.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Central Nervous System Stimulants; Child; Drug Eruptions; Female; Humans; Hypopigmentation; Male; Methylphenidate; Transdermal Patch; United States; United States Food and Drug Administration; Young Adult | 2017 |